OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a world, high-growth diagnostics firm, right now introduced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019, at 3:00 p.m. PT (6:00 p.m. ET). The convention shall be held at the Westin St. Francis Hotel in San Francisco.
A reside webcast of the presentation shall be out there on-line from the investor relations web page of the Company’s company web site at www.oxfordimmunotec.com. A webcast replay shall be out there roughly 24 hours after the reside presentation and shall be archived on the web site for roughly 90 days.
About Oxford Immunotec
Oxford Immunotec Global PLC is a world, high-growth diagnostics firm targeted on growing and commercializing proprietary assays for immunology and infectious illness. The Company’s T-SPOT®.TB take a look at has been accredited on the market in over 50 international locations, together with the United States, the place it has obtained pre-market approval from the Food and Drug Administration, Europe, the place it has obtained a CE mark, in addition to Japan and China. The Company is headquartered close to Oxford, U.Okay. and in Marlborough, MA. Additional info might be discovered at www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec emblem are logos of Oxford Immunotec Ltd.
For Media and Investor Inquiries:
VP, Strategy and Investor Relations
Tel: +1 (508) 556-1377